Metabolic profiling of triple-negative breast cancer cells reveals metabolic vulnerabilities

被引:0
作者
Nathan J. Lanning
Joshua P. Castle
Simar J. Singh
Andre N. Leon
Elizabeth A. Tovar
Amandeep Sanghera
Jeffrey P. MacKeigan
Fabian V. Filipp
Carrie R. Graveel
机构
[1] California State University,Systems Biology and Cancer Metabolism, Program for Quantitative Systems Biology
[2] Van Andel Research Institute,College of Human Medicine
[3] University of California Merced,undefined
[4] Michigan State University,undefined
来源
Cancer & Metabolism | / 5卷
关键词
Triple-negative breast cancer; Metabolism; Rate-limiting enzymes; Receptor tyrosine kinase; Tyrosine kinase inhibitor; Metabolic inhibitor;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 543 条
[31]  
Chakravarthy AB(2015)Metabolic reprogramming in triple-negative breast cancer through Myc suppression of TXNIP Proc Natl Acad Sci U S A 112 5425-470
[32]  
Shyr Y(2012)An integrated genomic screen identifies LDHB as an essential gene for triple-negative breast cancer Cancer Res 72 5812-2644
[33]  
Pietenpol JA(2013)Glucose promotes breast cancer aggression and reduces metformin efficacy Cell Cycle 12 3759-1712
[34]  
Burstein MD(2015)Pharmacogenomic and clinical data link non-pharmacokinetic metabolic dysregulation to drug side effect pathogenesis Nat Commun 6 7101-465
[35]  
Tsimelzon A(2014)Inhibition of PKM2 sensitizes triple-negative breast cancer cells to doxorubicin Biochem Biophys Res Commun 454 465-795
[36]  
Poage GM(2013)Mitochondrial complex I inhibitors and forced oxidative phosphorylation synergize in inducing cancer cell death Int J Cell Biol 2013 243876-204
[37]  
Covington KR(2012)Mitochondria-targeted drugs synergize with 2-deoxyglucose to trigger breast cancer cell death Cancer Res 72 2634-565
[38]  
Contreras A(2014)Statistical measures of transcriptional diversity capture genomic heterogeneity of cancer BMC Genomics 15 876-1112
[39]  
Fuqua SAW(2013)Metabolic phenotypes in triple-negative breast cancer Tumour Biol 34 1699-892
[40]  
Savage MI(2013)Metabolic interaction between cancer cells and stromal cells according to breast cancer molecular subtype Breast Cancer Res 15 R78-202